InvestorsHub Logo
icon url

dr_lowenstein

01/31/14 6:10 PM

#87763 RE: BigGreen101 #87761

You need to realize that elite is unlike any other drug company in the world. They have special technology even if the inventor is long gone. Elite is the only company in the entire world that can do adt. The pfizers and purdues of the world know this but they have so much money they are developing products just for grins. Actually elite is so special that the FDA told them not to bother doing any studies at all but elite is doing a few small ones for grins. Lol lol hysterically funny isn't it?
icon url

lasers

01/31/14 6:42 PM

#87771 RE: BigGreen101 #87761

Why would you doubt Camargo???. Elite Jan 10 trial for 52 persons for ELI-201 Xxx/Nal has been labelled as "Pivotal." Elite's Mar 2014 for ELI-201 Oxy/Nal has been labelled as "Pivotal"!!!. Perhaps you missed it but Elite's Dec 2013 trial was labelled "Pilot".


In some cases, a sponsor may decide to run what is referred to as a “Phase 2b” evaluation, which is a second, confirmatory Phase 2 clinical trial that could, if positive and accepted by the FDA, serve as a pivotal trial in the approval of a product candidate.



http://www.wikinvest.com/stock/Map_Pharmaceuticals_Inc_%28MAPP%29/New_Drug_Applications
icon url

StockSwami

02/01/14 1:20 PM

#87806 RE: BigGreen101 #87761

Do you even know the difference between a 505b2 and a 505b1 study????

I would also advise you to check out the last CC, then give us the answer on when the CEO said this would happen. I think I'll believe his word over yours, thank you very much....GLTA longs...looking better every day.